"Ricki Lewis' Law"

The Closing Bell for July 5 was headlined as a lament for the passing of eponyms in science.1 It is unlikely that we will soon dispose of Mendel's Laws or Avogadro's Number. If scientists are jealous about being properly cited in bibliographies, that is a large step towards an eponymic tradition. There may be less of the natural history and surprise observation in science today, but there is no lack of theoretical synthesis that might invite the dignity of being inscribed as a "Law."Self-anointe

Written byJoshua Lederberg
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The Closing Bell for July 5 was headlined as a lament for the passing of eponyms in science.1 It is unlikely that we will soon dispose of Mendel's Laws or Avogadro's Number. If scientists are jealous about being properly cited in bibliographies, that is a large step towards an eponymic tradition. There may be less of the natural history and surprise observation in science today, but there is no lack of theoretical synthesis that might invite the dignity of being inscribed as a "Law."

Self-anointed "Laws" are likely to attach to matters the author is uncertain about, hence need dogmatic assertion. There is no Lederberg's Law in print of which I'm aware; in my correspondence I do find: (October 2001) "An aphorism that is sometimes called (one of) Lederberg's laws: Knowledge-based systems are up against a stonewall until computer programs can read the literature firsthand; and the latter will have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies